Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Ampio Pharm stock

Learn how to easily invest in Ampio Pharm stock.

Ampio Pharm is a biotechnology business based in the US. Ampio Pharm shares (AMPE) are listed on the NYSE MKT and all prices are listed in US Dollars. Ampio Pharm employs 9 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Ampio Pharm stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – AMPE. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance



  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Ampio Pharm stock price (NYSE MKT: AMPE)

Use our graph to track the performance of AMPE stocks over time.

Ampio Pharm shares at a glance

Information last updated 2023-01-25.
Latest market close$0.28
52-week range$0.20 - $9.71
50-day moving average $0.31
200-day moving average $1.75
Wall St. target price$2.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.12

Buy Ampio Pharm stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Ampio Pharm stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ampio Pharm price performance over time

Historical closes compared with the close of $0.2835 from 2023-01-26

1 week (2023-01-20) 5.00%
1 month (2022-12-27) 28.45%
3 months (2022-10-27) 845.00%
6 months (2022-07-27) 77.19%
1 year (2022-01-24) -40.94%
2 years (2021-01-27) -81.94%
3 years (2020-01-27) 0.692
5 years (2018-01-26) 2.72

Ampio Pharm financials

Gross profit TTM $0
Return on assets TTM -81.42%
Return on equity TTM -130.71%
Profit margin 0%
Book value $0.92
Market capitalisation $4.1 million

TTM: trailing 12 months

Ampio Pharm share dividends

We're not expecting Ampio Pharm to pay a dividend over the next 12 months.

Have Ampio Pharm's shares ever split?

Ampio Pharm's shares were split on a 1:15 basis on 9 November 2022. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ampio Pharm shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Ampio Pharm shares which in turn could have impacted Ampio Pharm's share price.

Ampio Pharm share price volatility

Over the last 12 months, Ampio Pharm's shares have ranged in value from as little as $0.199 up to $9.705. A popular way to gauge a stock's volatility is its "beta".

AMPE.US volatility(beta: 1.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ampio Pharm's is 1.685. This would suggest that Ampio Pharm's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Ampio Pharm overview

Ampio Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado. .

Frequently asked questions

What percentage of Ampio Pharm is owned by insiders or institutions?
Currently 7.506% of Ampio Pharm shares are held by insiders and 13.026% by institutions.
How many people work for Ampio Pharm?
Latest data suggests 9 work at Ampio Pharm.
When does the fiscal year end for Ampio Pharm?
Ampio Pharm's fiscal year ends in December.
Where is Ampio Pharm based?
Ampio Pharm's address is: 373 Inverness Parkway, Englewood, CO, United States, 80112
What is Ampio Pharm's ISIN number?
Ampio Pharm's international securities identification number is: US03209T1097
What is Ampio Pharm's CUSIP number?
Ampio Pharm's Committee on Uniform Securities Identification Procedures number is: 03209T109

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site